Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Toward cure chronic hepatitis B infection and hepatocellular carcinoma prevention: Lessons learned from nucleos(t)ide analogues therapy.

Tavakolpour S, Mirsafaei HS, Elkaei Behjati S, Ghasemiadl M, Akhlaghdoust M, Sali S.

Immunol Lett. 2017 Oct;190:206-212. doi: 10.1016/j.imlet.2017.08.003. Epub 2017 Aug 5. Review.

PMID:
28827021
2.

Comparison of Vitamin D Levels in Naive, Treated, and Inactive Carriers with Chronic Hepatitis B Virus.

Sali S, Tavakolpour S, Farkhondemehr B.

J Clin Transl Hepatol. 2016 Dec 28;4(4):306-309. doi: 10.14218/JCTH.2016.00037. Epub 2016 Dec 27.

3.

Manipulation of Regulatory Cells' Responses to Treatments for Chronic Hepatitis B Virus Infection.

Tavakolpour S, Alavian SM, Sali S.

Hepat Mon. 2016 May 25;16(6):e37927. doi: 10.5812/hepatmon.37927. eCollection 2016 Jun.

4.

Hepatitis B Reactivation During Immunosuppressive Therapy or Cancer Chemotherapy, Management, and Prevention: A Comprehensive Review-Screened.

Tavakolpour S, Alavian SM, Sali S.

Hepat Mon. 2016 Mar 26;16(4):e35810. doi: 10.5812/hepatmon.35810. eCollection 2016 Apr. Review.

5.

Tumor Necrosis Factor-α-308 G/A Polymorphisms and Risk of Hepatocellular Carcinoma: A Meta-Analysis.

Tavakolpour S, Sali S.

Hepat Mon. 2016 Apr 12;16(4):e33537. doi: 10.5812/hepatmon.33537. eCollection 2016 Apr. Review.

6.

Association of Plasma Levels of Vitamin D With Chronic Hepatitis B Infection.

Tavakolpour S, Sali S, Gachkar L.

Hepat Mon. 2016 Jan 16;16(1):e35525. doi: 10.5812/hepatmon.35525. eCollection 2016 Jan. No abstract available.

7.

Multiple intracranial tuberculomas in a post-kidney transplant patient.

Yadegarynia D, Merza MA, Sali S, Seghatoleslami ZS.

Saudi J Kidney Dis Transpl. 2016 Jan;27(1):135-8. doi: 10.4103/1319-2442.174163.

8.

Seroclearance of Hbsag in Chronic Hepatitis B Virus Patients on Lamivudine Therapy: A 10 Year Experience.

Sali S, Merza MA, Saadat S, Mustafa NH, Queiky F, Yadegarynia D.

Glob J Health Sci. 2015 Apr 2;7(6):101-7. doi: 10.5539/gjhs.v7n6p101.

9.

Can serum level of HBsAg differentiate HBeAg-negative chronic hepatitis B from inactive carrier state?

Sali S, Sharafi H, Alavian SH, Alavian SM, Etesam F, Salimi S, Merza MA, Keshvari M.

Diagn Microbiol Infect Dis. 2015 Jun;82(2):114-9. doi: 10.1016/j.diagmicrobio.2015.02.005. Epub 2015 Feb 20.

PMID:
25863529
10.

Non-invasive histologic markers of liver disease in patients with chronic hepatitis B.

Shoaei SD, Sali S, Karamipour M, Riahi E.

Hepat Mon. 2014 Feb 28;14(2):e14228. doi: 10.5812/hepatmon.14228. eCollection 2014 Feb.

11.

Influencing Factors on the Outcome and Prognosis of Patients With HBV Infction: Seven Years Follow-up.

Sali S, Alavian SM, Foster GR, Keyvani H, Mehrnoosh L, Mohammadi N.

Hepat Mon. 2013 Jul 8;13(7):e8743. doi: 10.5812/hepatmon.8743. eCollection 2013.

12.

Occupational exposure to blood borne viruses among healthcare workers in a tertiary care referral hospital in tehran.

Sali S, Merza MA, Yadegarinia D.

Hepat Mon. 2013 Jul 1;13(7):e12201. doi: 10.5812/hepatmon.12201. eCollection 2013. No abstract available.

13.

A rare case presentation of oral actinomycosis.

Yadegarynia D, Merza MA, Sali S, Firuzkuhi AG.

Int J Mycobacteriol. 2013 Sep;2(3):187-9. doi: 10.1016/j.ijmyco.2013.06.002. Epub 2013 Jul 19.

14.

Real response to therapy in chronic hepatitis C virus patients: a study from iran.

Namazee N, Sali S, Asadi S, Shafiei M, Behnava B, Alavian SM.

Hepat Mon. 2012 Sep;12(9):e6151. doi: 10.5812/hepatmon.6151. Epub 2012 Sep 15.

15.

Effect of levamisole supplementation on hepatitis B virus vaccination response in hemodialysis patients.

Sali S, Alavian SM, Hajarizadeh B.

Nephrology (Carlton). 2008 Oct;13(5):376-9. doi: 10.1111/j.1440-1797.2008.00952.x. Epub 2008 May 29.

PMID:
18518938

Supplemental Content

Loading ...
Support Center